0.4838
price down icon1.51%   -0.0074
after-market After Hours: .49 0.0062 +1.28%
loading
Tenaya Therapeutics Inc stock is traded at $0.4838, with a volume of 1.68M. It is down -1.51% in the last 24 hours and down -24.69% over the past month. Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$0.4912
Open:
$0.49
24h Volume:
1.68M
Relative Volume:
0.58
Market Cap:
$74.52M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-0.3665
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
+5.59%
1M Performance:
-24.69%
6M Performance:
-76.74%
1Y Performance:
-88.77%
1-Day Range:
Value
$0.48
$0.51
1-Week Range:
Value
$0.4419
$0.5334
52-Week Range:
Value
$0.40
$4.96

Tenaya Therapeutics Inc Stock (TNYA) Company Profile

Name
Name
Tenaya Therapeutics Inc
Name
Phone
415-865-2066
Name
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Name
Employee
97
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
TNYA's Discussions on Twitter

Compare TNYA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TNYA
Tenaya Therapeutics Inc
0.4838 74.52M 0 -111.13M -91.53M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-10-24 Initiated William Blair Outperform
Nov-30-23 Initiated Leerink Partners Outperform
Jun-15-22 Initiated H.C. Wainwright Buy

Tenaya Therapeutics Inc Stock (TNYA) Latest News

pulisher
01:11 AM

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

01:11 AM
pulisher
Apr 25, 2025

H.C. Wainwright maintains Buy on Tenaya Therapeutics stock By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

H.C. Wainwright maintains Buy on Tenaya Therapeutics stock - Investing.com

Apr 25, 2025
pulisher
Apr 24, 2025

Tenaya reports progress in ARVC gene therapy study - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Tenaya Therapeutics Presents Interim Data from RIDGE™ - GlobeNewswire

Apr 24, 2025
pulisher
Apr 24, 2025

Major Breakthrough: 175-Patient ARVC Study Shows 93% Could Benefit from New Gene Therapy Treatment - Stock Titan

Apr 24, 2025
pulisher
Apr 18, 2025

Tenaya Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 18, 2025

Tenaya Therapeutics faces Nasdaq delisting over share price - Investing.com Australia

Apr 18, 2025
pulisher
Apr 04, 2025

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee - The Manila Times

Apr 04, 2025
pulisher
Apr 03, 2025

Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com

Apr 03, 2025
pulisher
Apr 01, 2025

Tenaya highlights HCM gene therapy interim data at ACC 2025 - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

Tenaya to lay off about one-third of staff, reveals heart gene therapy data - Endpoints News

Mar 31, 2025
pulisher
Mar 31, 2025

Top 3 Insider Stock Buys in March-Are They Still Good in April? - MSN

Mar 31, 2025
pulisher
Mar 31, 2025

Tenaya Therapeutics Announces Late Breaker Presentation - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Revolutionary Gene Therapy Transforms Severe Heart Disease Patients in Landmark Trial - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting - The Manila Times

Mar 31, 2025
pulisher
Mar 28, 2025

Undervalued Cardiology Stocks to Watch: TNYA, MIST, BBIO, ALNY - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

Tenaya Therapeutics IncOn Mar 27, Co Approves Restructuring PlanSEC Filing - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Is Tenaya Therapeutics, Inc. (TNYA) the Cheapest Stock Insiders Are Buying In March? - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

FY2025 Earnings Estimate for TNYA Issued By Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Tenaya Therapeutics, Inc. (TNYA): Among Stocks Receiving the Most Insider Love in March - Yahoo

Mar 25, 2025
pulisher
Mar 25, 2025

Top 3 Insider Stock Buys in March—Are They Still Good in April? - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Tenaya Therapeutics publishes preclinical data on TN-201 in cardiac function - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

15 Cheapest Stocks Insiders Are Buying In March - Insider Monkey

Mar 25, 2025
pulisher
Mar 24, 2025

Breakeven On The Horizon For Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - simplywall.st

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya reports promising gene therapy for heart condition By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya Therapeutics Says Gene Therapy Candidate Improves Heart Function in Preclinical Trial - MarketScreener

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya reports promising gene therapy for heart condition - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) stock price dropped 13% last week; individual investors would not be happy - Yahoo

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Revolutionary Heart Disease Treatment: Gene Therapy Reverses Cardiac Damage in Landmark Study - Stock Titan

Mar 24, 2025
pulisher
Mar 22, 2025

Tenaya Therapeutics announces $300M mixed shelf offering; shares down - MSN

Mar 22, 2025
pulisher
Mar 21, 2025

Tenaya Therapeutics files for mixed shelf offering of up to $300 mln -March 21, 2025 at 04:16 pm EDT - MarketScreener

Mar 21, 2025
pulisher
Mar 20, 2025

Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey

Mar 20, 2025
pulisher
Mar 19, 2025

Tenaya Therapeutics to Present New Data on MYBPC3-Associated Hypertrophic Cardiomyopathy at ACC 2025 Annual Scientific Session - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

Tenaya Therapeutics Announces Late Breaker and New Data - GlobeNewswire

Mar 19, 2025
pulisher
Mar 19, 2025

Major Breakthrough: Tenaya's Gene Therapy Trial Reveals Critical One-Year Heart Disease Data - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session - Yahoo Finance

Mar 19, 2025
pulisher
Mar 15, 2025

Canaccord Genuity Group Lowers Tenaya Therapeutics (NASDAQ:TNYA) Price Target to $6.00 - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

Analysts Issue Forecasts for TNYA Q1 Earnings - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Morgan Stanley Has Lowered Expectations for Tenaya Therapeutics (NASDAQ:TNYA) Stock Price - Defense World

Mar 14, 2025

Tenaya Therapeutics Inc Stock (TNYA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Cap:     |  Volume (24h):